0000000000419923

AUTHOR

Anne-ségolène Cottereau

0000-0002-4805-4564

showing 2 related works from this author

Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies

2016

Purpose Identifying patients at high risk of progression and early death among those with high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models. This study aimed to determine the prognostic impact of the total metabolic tumor volume (TMTV) measured at baseline with [18F]fluorodeoxyglucose/positron emission tomography-computed tomography ([18F]FDG/PET-CT) scans and its added value to these models. Patients and Methods A pooled analysis was performed by using patient data and centrally reviewed baseline PET-CT scans for 185 patients with FL who were receiving immunochemotherapy within three prospective trials. TMTV was computed by using the 41% maximum st…

OncologyFluorodeoxyglucoseCancer Researchmedicine.medical_specialtybusiness.industryFollicular lymphomaStandardized uptake valueMetabolic tumor volumemedicine.disease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePooled analysisInternational Prognostic IndexOncology030220 oncology & carcinogenesisInternal medicineMedicinePositron emissionStage (cooking)businessNuclear medicinemedicine.drugJournal of Clinical Oncology
researchProduct

Deauville score evaluationof PET2 positive patients included in the H10 trial

2018

IF 7.704 (2017)Communication donnée lors du 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Dusseldorf, Germany, du 13 au 17 octobre 2018; International audience

Nuclear Medicine & Medical Imaging[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRadiology[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct